The Clorox Company (NYSE:CLX) Shares Sold by Larson Financial Group LLC

Larson Financial Group LLC lowered its position in shares of The Clorox Company (NYSE:CLX) by 16.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,412 shares of the company’s stock after selling 481 shares during the quarter. Larson Financial Group LLC’s holdings in Clorox were worth $393,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of CLX. Mizuho Securities USA LLC lifted its stake in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Nuance Investments LLC lifted its position in Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after buying an additional 960,094 shares during the period. Van ECK Associates Corp boosted its stake in Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Clorox by 14.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after buying an additional 120,716 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in shares of Clorox by 11.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company’s stock valued at $109,483,000 after acquiring an additional 85,529 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research analyst reports. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. DA Davidson boosted their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Evercore ISI cut their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. JPMorgan Chase & Co. boosted their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their price target for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $155.00.

Clorox Trading Up 0.6 %

NYSE CLX opened at $167.34 on Wednesday. The stock has a market cap of $20.71 billion, a P/E ratio of 58.31, a PEG ratio of 3.13 and a beta of 0.41. The company’s fifty day simple moving average is $162.84 and its 200-day simple moving average is $148.88. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.35.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.49 EPS. Equities research analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.57% of the stock is owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.